377 related articles for article (PubMed ID: 23841899)
21. Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.
Wang Y; Sinha S; Wellik LE; Secreto CR; Rech KL; Call TG; Parikh SA; Kenderian SS; Muchtar E; Hayman SR; Koehler AB; Van Dyke DL; Leis JF; Slager SL; Dong H; Kay NE; He R; Ding W
Blood Cancer J; 2021 May; 11(5):86. PubMed ID: 33972504
[TBL] [Abstract][Full Text] [Related]
22. Richter Syndrome in Chronic Lymphocytic Leukemia.
Vitale C; Ferrajoli A
Curr Hematol Malig Rep; 2016 Feb; 11(1):43-51. PubMed ID: 26830086
[TBL] [Abstract][Full Text] [Related]
23. Richter syndrome: biology, incidence, and therapeutic strategies.
Tsimberidou AM; Keating MJ
Cancer; 2005 Jan; 103(2):216-28. PubMed ID: 15578683
[TBL] [Abstract][Full Text] [Related]
24. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia.
Robak T
Hematology; 2004; 9(5-6):387-400. PubMed ID: 15763979
[TBL] [Abstract][Full Text] [Related]
25. Extranodal NK/T cell lymphoma and lymphomatoid granulomatosis in a patient with chronic lymphocytic leukaemia: Case report for a new perspective on Richter syndrome.
Abi-Rafeh J; Beamish IV; Haegert DG; Cournoyer D; Michel RP
Medicine (Baltimore); 2020 May; 99(19):e20106. PubMed ID: 32384485
[TBL] [Abstract][Full Text] [Related]
26. Richter syndrome in B-cell chronic lymphocytic leukemia.
Nakamura N; Abe M
Pathol Int; 2003 Apr; 53(4):195-203. PubMed ID: 12675762
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
[TBL] [Abstract][Full Text] [Related]
28. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
Parikh SA; Habermann TM; Chaffee KG; Call TG; Ding W; Leis JF; Macon WR; Schwager SM; Ristow KM; Porrata LF; Kay NE; Slager SL; Shanafelt TD
Am J Hematol; 2015 Apr; 90(4):334-8. PubMed ID: 25581025
[TBL] [Abstract][Full Text] [Related]
29. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma.
Rinaldi A; Mensah AA; Kwee I; Forconi F; Orlandi EM; Lucioni M; Gattei V; Marasca R; Berger F; Cogliatti S; Cavalli F; Zucca E; Gaidano G; Rossi D; Bertoni F
Br J Haematol; 2013 Oct; 163(2):194-204. PubMed ID: 23961875
[TBL] [Abstract][Full Text] [Related]
30. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
Rasi S; Spina V; Bruscaggin A; Vaisitti T; Tripodo C; Forconi F; De Paoli L; Fangazio M; Sozzi E; Cencini E; Laurenti L; Marasca R; Visco C; Xu-Monette ZY; Gattei V; Young KH; Malavasi F; Deaglio S; Gaidano G; Rossi D
Br J Haematol; 2011 Feb; 152(3):284-94. PubMed ID: 21121903
[TBL] [Abstract][Full Text] [Related]
31. Clinical and molecular characteristics and treatment patterns of adolescent and young adult patients with chronic lymphocytic leukaemia.
Cherng HJ; Jammal N; Paul S; Wang X; Sasaki K; Thompson P; Burger J; Ferrajoli A; Estrov Z; O'Brien S; Keating M; Wierda WG; Jain N
Br J Haematol; 2021 Jul; 194(1):61-68. PubMed ID: 33973230
[TBL] [Abstract][Full Text] [Related]
32. Richter Transformation Arising From Chronic Lymphocytic Leukemia.
Barnes Rogers B
Clin J Oncol Nurs; 2022 Feb; 26(1):14-17. PubMed ID: 35073287
[TBL] [Abstract][Full Text] [Related]
33. The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation.
Visentin A; Bonaldi L; Rigolin GM; Mauro FR; Martines A; Frezzato F; Pravato S; Gargarella LR; Bardi MA; Cavallari M; Volta E; Cavazzini F; Nanni M; Facco M; Piazza F; Guarini A; Foà R; Semenzato G; Cuneo A; Trentin L
Haematologica; 2022 Apr; 107(4):868-876. PubMed ID: 34092056
[TBL] [Abstract][Full Text] [Related]
34. Richter transformation with c-MYC overexpression: report of three cases.
Wang L; Aghel A; Peterson B; Wang-Rodriguez J; Wang HY; Zhao XF
Int J Clin Exp Pathol; 2015; 8(6):7540-6. PubMed ID: 26261666
[TBL] [Abstract][Full Text] [Related]
35. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome.
Chigrinova E; Rinaldi A; Kwee I; Rossi D; Rancoita PM; Strefford JC; Oscier D; Stamatopoulos K; Papadaki T; Berger F; Young KH; Murray F; Rosenquist R; Greiner TC; Chan WC; Orlandi EM; Lucioni M; Marasca R; Inghirami G; Ladetto M; Forconi F; Cogliatti S; Votavova H; Swerdlow SH; Stilgenbauer S; Piris MA; Matolcsy A; Spagnolo D; Nikitin E; Zamò A; Gattei V; Bhagat G; Ott G; Zucca E; Gaidano G; Bertoni F
Blood; 2013 Oct; 122(15):2673-82. PubMed ID: 24004666
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia transformation into high-grade lymphoma: a description of Richter's syndrome in eight dogs.
Comazzi S; Martini V; Riondato F; Poggi A; Stefanello D; Marconato L; Albonico F; Gelain ME
Vet Comp Oncol; 2017 Jun; 15(2):366-373. PubMed ID: 26463596
[TBL] [Abstract][Full Text] [Related]
37. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease--case report.
Salihoglu A; Ozbalak M; Keskin D; Tecimer T; Soysal T; Ferhanoglu B
Transplant Proc; 2013 Sep; 45(7):2845-8. PubMed ID: 23747187
[TBL] [Abstract][Full Text] [Related]
38. Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort study.
Hleuhel MH; Ben-Dali Y; Da Cunha-Bang C; Brieghel C; Clasen-Linde E; Niemann CU; Andersen MA
BMJ Open; 2019 Mar; 9(3):e023566. PubMed ID: 30833314
[TBL] [Abstract][Full Text] [Related]
39. Richter transformation in the era of novel agents.
Ding W
Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):256-263. PubMed ID: 30504319
[TBL] [Abstract][Full Text] [Related]
40. EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient.
Janssens A; Berth M; De Paepe P; Verhasselt B; Van Roy N; Noens L; Philippé J; Offner F
Am J Hematol; 2006 Sep; 81(9):706-12. PubMed ID: 16838338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]